Mezzopram

Omeprazole, the active ingredient in Mezzopram, is a proton pump inhibitor presented as an oral tablet for oral use. It treats acid‑related disorders such as gastro‑oesophageal reflux disease, peptic ulcer disease and is used in Helicobacter pylori eradication regimens.

GNH USA supplies Mezzopram as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is a proton pump inhibitor used to manage conditions caused by excess gastric acid.

Gastro‑oesophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of esophageal irritation. Peptic ulcer disease: promotes ulcer healing and prevents recurrence. Helicobacter pylori eradication (in combination therapy): enhances bacterial eradication when combined with antibiotics. Prevention of NSAID‑induced gastric ulcers: lowers risk of ulcer formation in patients taking non‑steroidal anti‑inflammatory drugs.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Abdominal pain: discomfort in the upper abdomen. - Diarrhoea: loose stools occurring intermittently. - Nausea: feeling of queasiness. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Severe allergic reactions: including anaphylaxis. - Stevens‑Johnson syndrome: rare skin disorder. - Elevated liver enzymes: indicating hepatic stress. - Hypomagnesemia: low magnesium levels with prolonged use. - Interstitial nephritis: kidney inflammation.

Before initiating therapy, consider the following safety measures.

Assess renal function: adjust use in patients with severe renal impairment. Monitor hepatic status: use cautiously in liver disease. Avoid in known hypersensitivity: discontinue if allergic reaction occurs. Check magnesium levels: especially during long‑term treatment. Use lower dose in elderly: age‑related pharmacokinetic changes. Store at room temperature: keep in the original pack, protect from moisture.

Omeprazole can affect the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet activation. - Atazanavir: decreased antiviral efficacy. - Methotrexate: increased toxicity risk.

Moderate Interactions (Monitor Closely): - Digoxin: possible increased serum levels. - Phenytoin: altered anticonvulsant concentrations.